Added to YB: 2024-12-04
Pitch date: 2024-12-03
BELL.L [neutral]
Belluscura plc
-92.68%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Belluscura plc develops and commercialize oxygen related medical device products in the United States.
Market Cap
GBP 4.0M
Pitch Price
GBP 0.10
Price Target
0.35 (+4567%)
Dividend
N/A
EV/EBITDA
-0.18
P/E
-0.19
EV/Sales
1.71
Sector
Health Care Equipment and Supplies
Category
growth
Show full summary:
Belluscura: Undervalued with Significant Potential in Portable Oxygen and Wound Care
BELL.L: JV with major medical device co for oxygen-based wound care, targeting $22.5bn market with 5.9% CAGR. DFU treatment potential. Clinical trials Q2'25. £17m mkt cap vs £137m for AOTI. FY25 rev est $20M, EBITDA $0.8M. 35p target. Cash concerns, may need capital for DISCOV-R launch.
Read full article (2 min)